Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06899529 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Study acronym: Postop IVA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Patients undergoing surgery for complications related to diabetes will be recruited.
Trial Details
NCT Number NCT06899529
Lead Sponsor Christian Ophthalmic Surgery Expedition Network
Conditions
(from sponsor)		 Proliferative Diabetic Retinopathy - High Risk
Related terms Vitreous Hemorrhage
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov